nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—NR3C2—Preimplantation Embryo—MYBL1—malignant glioma	0.0355	0.0657	CbGpPWpGaD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—BDKRB2—malignant glioma	0.0302	0.0558	CbGpPWpGaD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—KNG1—malignant glioma	0.0274	0.0508	CbGpPWpGaD
Fludrocortisone—Intracranial pressure increased—Carmustine—malignant glioma	0.0261	0.0747	CcSEcCtD
Fludrocortisone—Impaired healing—Carmustine—malignant glioma	0.0252	0.0721	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—LATS2—malignant glioma	0.0209	0.0387	CbGpPWpGaD
Fludrocortisone—Skin hyperpigmentation—Carmustine—malignant glioma	0.0183	0.0525	CcSEcCtD
Fludrocortisone—NR3C2—Preimplantation Embryo—SOX2—malignant glioma	0.0155	0.0286	CbGpPWpGaD
Fludrocortisone—Myopathy—Temozolomide—malignant glioma	0.015	0.043	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—XBP1—malignant glioma	0.0132	0.0245	CbGpPWpGaD
Fludrocortisone—Petechiae—Temozolomide—malignant glioma	0.0128	0.0366	CcSEcCtD
Fludrocortisone—Amenorrhoea—Temozolomide—malignant glioma	0.012	0.0343	CcSEcCtD
Fludrocortisone—Neoplasm—Carmustine—malignant glioma	0.00986	0.0282	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—HEY2—malignant glioma	0.00986	0.0182	CbGpPWpGaD
Fludrocortisone—AR—FOXA1 transcription factor network—CYP2C18—malignant glioma	0.00962	0.0178	CbGpPWpGaD
Fludrocortisone—Neoplasm—Temozolomide—malignant glioma	0.00953	0.0273	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Carmustine—malignant glioma	0.00914	0.0262	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—HEY1—malignant glioma	0.00913	0.0169	CbGpPWpGaD
Fludrocortisone—Diabetes mellitus—Carmustine—malignant glioma	0.0091	0.026	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Temozolomide—malignant glioma	0.00884	0.0253	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—MYB—malignant glioma	0.00879	0.0163	CbGpPWpGaD
Fludrocortisone—Injury—Carmustine—malignant glioma	0.00861	0.0246	CcSEcCtD
Fludrocortisone—Vascular purpura—Temozolomide—malignant glioma	0.00855	0.0245	CcSEcCtD
Fludrocortisone—NR3C2—brainstem—malignant glioma	0.00849	0.0878	CbGeAlD
Fludrocortisone—NR3C2—retina—malignant glioma	0.00819	0.0847	CbGeAlD
Fludrocortisone—Purpura—Temozolomide—malignant glioma	0.00794	0.0227	CcSEcCtD
Fludrocortisone—NR3C2—telencephalon—malignant glioma	0.00753	0.0779	CbGeAlD
Fludrocortisone—Affect lability—Temozolomide—malignant glioma	0.00753	0.0215	CcSEcCtD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—NF1—malignant glioma	0.0073	0.0135	CbGpPWpGaD
Fludrocortisone—Mood swings—Temozolomide—malignant glioma	0.00725	0.0207	CcSEcCtD
Fludrocortisone—Muscular weakness—Carmustine—malignant glioma	0.00698	0.02	CcSEcCtD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.0068	0.0126	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Temozolomide—malignant glioma	0.00675	0.0193	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—PTK2—malignant glioma	0.00672	0.0124	CbGpPWpGaD
Fludrocortisone—Abdominal distension—Temozolomide—malignant glioma	0.00666	0.019	CcSEcCtD
Fludrocortisone—Sweating increased—Temozolomide—malignant glioma	0.00644	0.0184	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Carmustine—malignant glioma	0.00617	0.0177	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—RUNX3—malignant glioma	0.00616	0.0114	CbGpPWpGaD
Fludrocortisone—Hyperglycaemia—Temozolomide—malignant glioma	0.00596	0.0171	CcSEcCtD
Fludrocortisone—NR3C1—Signaling events mediated by HDAC Class II—YWHAE—malignant glioma	0.00593	0.011	CbGpPWpGaD
Fludrocortisone—NR3C2—medulla oblongata—malignant glioma	0.00592	0.0612	CbGeAlD
Fludrocortisone—AR—telencephalon—malignant glioma	0.00558	0.0577	CbGeAlD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—malignant glioma	0.00553	0.0102	CbGpPWpGaD
Fludrocortisone—AR—FOXA1 transcription factor network—SOD1—malignant glioma	0.00553	0.0102	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Carmustine—malignant glioma	0.0055	0.0157	CcSEcCtD
Fludrocortisone—Haemorrhage—Carmustine—malignant glioma	0.00548	0.0157	CcSEcCtD
Fludrocortisone—NR3C2—midbrain—malignant glioma	0.00541	0.056	CbGeAlD
Fludrocortisone—Haemoglobin—Temozolomide—malignant glioma	0.00532	0.0152	CcSEcCtD
Fludrocortisone—Haemorrhage—Temozolomide—malignant glioma	0.00529	0.0151	CcSEcCtD
Fludrocortisone—NR3C2—spinal cord—malignant glioma	0.00528	0.0546	CbGeAlD
Fludrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—malignant glioma	0.00514	0.00951	CbGpPWpGaD
Fludrocortisone—NR3C1—embryo—malignant glioma	0.00497	0.0514	CbGeAlD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MYB—malignant glioma	0.00485	0.00897	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—SOX2—malignant glioma	0.00479	0.00887	CbGpPWpGaD
Fludrocortisone—Erythema—Carmustine—malignant glioma	0.00477	0.0136	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—HES1—malignant glioma	0.00473	0.00875	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—NCOR1—malignant glioma	0.0047	0.0087	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—malignant glioma	0.00469	0.00869	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—malignant glioma	0.00467	0.00865	CbGpPWpGaD
Fludrocortisone—Erythema—Temozolomide—malignant glioma	0.00461	0.0132	CcSEcCtD
Fludrocortisone—NR3C1—brainstem—malignant glioma	0.00455	0.0471	CbGeAlD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—malignant glioma	0.00432	0.008	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAE—malignant glioma	0.00431	0.00798	CbGpPWpGaD
Fludrocortisone—NR3C2—central nervous system—malignant glioma	0.00428	0.0443	CbGeAlD
Fludrocortisone—NR3C2—cerebellum—malignant glioma	0.00418	0.0433	CbGeAlD
Fludrocortisone—Vertigo—Temozolomide—malignant glioma	0.00414	0.0118	CcSEcCtD
Fludrocortisone—Convulsion—Carmustine—malignant glioma	0.00413	0.0118	CcSEcCtD
Fludrocortisone—Hypertension—Carmustine—malignant glioma	0.00412	0.0118	CcSEcCtD
Fludrocortisone—Myalgia—Carmustine—malignant glioma	0.00406	0.0116	CcSEcCtD
Fludrocortisone—NR3C1—telencephalon—malignant glioma	0.00404	0.0418	CbGeAlD
Fludrocortisone—AR—Nuclear Receptors—PPARG—malignant glioma	0.00399	0.00739	CbGpPWpGaD
Fludrocortisone—Convulsion—Temozolomide—malignant glioma	0.00399	0.0114	CcSEcCtD
Fludrocortisone—Hypertension—Temozolomide—malignant glioma	0.00398	0.0114	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—HIF1A—malignant glioma	0.00396	0.00734	CbGpPWpGaD
Fludrocortisone—Myalgia—Temozolomide—malignant glioma	0.00392	0.0112	CcSEcCtD
Fludrocortisone—AR—spinal cord—malignant glioma	0.00391	0.0404	CbGeAlD
Fludrocortisone—Oedema—Carmustine—malignant glioma	0.00389	0.0111	CcSEcCtD
Fludrocortisone—Infection—Carmustine—malignant glioma	0.00387	0.0111	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.00385	0.00712	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—RAF1—malignant glioma	0.00382	0.00708	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—KDR—malignant glioma	0.00379	0.00702	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Temozolomide—malignant glioma	0.00376	0.0108	CcSEcCtD
Fludrocortisone—Oedema—Temozolomide—malignant glioma	0.00376	0.0108	CcSEcCtD
Fludrocortisone—Infection—Temozolomide—malignant glioma	0.00374	0.0107	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.00365	0.00675	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Temozolomide—malignant glioma	0.00363	0.0104	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—NF1—malignant glioma	0.00359	0.00664	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—NOTCH1—malignant glioma	0.00357	0.00661	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00354	0.0101	CcSEcCtD
Fludrocortisone—Insomnia—Carmustine—malignant glioma	0.00352	0.0101	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—PLK1—malignant glioma	0.00352	0.00651	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00343	0.0098	CcSEcCtD
Fludrocortisone—Insomnia—Temozolomide—malignant glioma	0.0034	0.00973	CcSEcCtD
Fludrocortisone—NR3C2—brain—malignant glioma	0.0034	0.0352	CbGeAlD
Fludrocortisone—AR—SIDS Susceptibility Pathways—MYB—malignant glioma	0.00336	0.00623	CbGpPWpGaD
Fludrocortisone—Methyltestosterone—CYP2B6—malignant glioma	0.00329	0.243	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.00325	0.00602	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—malignant glioma	0.00321	0.00594	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MSH2—malignant glioma	0.00318	0.00589	CbGpPWpGaD
Fludrocortisone—NR3C1—medulla oblongata—malignant glioma	0.00317	0.0328	CbGeAlD
Fludrocortisone—AR—central nervous system—malignant glioma	0.00317	0.0328	CbGeAlD
Fludrocortisone—Triamcinolone—BCHE—malignant glioma	0.00317	0.233	CrCbGaD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.00316	0.00584	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—NCOR1—malignant glioma	0.00315	0.00582	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—NCOR1—malignant glioma	0.00304	0.00563	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—PPARG—malignant glioma	0.00303	0.00561	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—GJA1—malignant glioma	0.00299	0.00554	CbGpPWpGaD
Fludrocortisone—Urticaria—Temozolomide—malignant glioma	0.00299	0.00855	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—PML—malignant glioma	0.00297	0.0055	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—malignant glioma	0.00292	0.0054	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.00292	0.0054	CbGpPWpGaD
Fludrocortisone—NR3C1—midbrain—malignant glioma	0.0029	0.03	CbGeAlD
Fludrocortisone—AR—Androgen receptor signaling pathway—PTK2—malignant glioma	0.00289	0.00535	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Carmustine—malignant glioma	0.00287	0.0082	CcSEcCtD
Fludrocortisone—NR3C1—spinal cord—malignant glioma	0.00283	0.0293	CbGeAlD
Fludrocortisone—AR—Androgen receptor signaling pathway—NCOR1—malignant glioma	0.00282	0.00522	CbGpPWpGaD
Fludrocortisone—Asthenia—Carmustine—malignant glioma	0.00279	0.00799	CcSEcCtD
Fludrocortisone—Hypersensitivity—Temozolomide—malignant glioma	0.00277	0.00792	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.00277	0.00512	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.00276	0.00512	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—malignant glioma	0.00271	0.00501	CbGpPWpGaD
Fludrocortisone—Asthenia—Temozolomide—malignant glioma	0.0027	0.00772	CcSEcCtD
Fludrocortisone—NR3C1—Circadian Clock—HIF1A—malignant glioma	0.00265	0.00491	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—MYB—malignant glioma	0.00255	0.00473	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.00253	0.00468	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.00253	0.00468	CbGpPWpGaD
Fludrocortisone—AR—brain—malignant glioma	0.00252	0.026	CbGeAlD
Fludrocortisone—AR—Regulation of Androgen receptor activity—MDM2—malignant glioma	0.0025	0.00462	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—malignant glioma	0.00249	0.00461	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.00247	0.00456	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.00246	0.00456	CbGpPWpGaD
Fludrocortisone—Headache—Carmustine—malignant glioma	0.00244	0.00697	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—malignant glioma	0.00243	0.0045	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.00239	0.00443	CbGpPWpGaD
Fludrocortisone—Headache—Temozolomide—malignant glioma	0.00236	0.00674	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—malignant glioma	0.00231	0.00427	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CDKN2A—malignant glioma	0.0023	0.00426	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CAV1—malignant glioma	0.0023	0.00426	CbGpPWpGaD
Fludrocortisone—NR3C1—central nervous system—malignant glioma	0.0023	0.0238	CbGeAlD
Fludrocortisone—NR3C1—AP-1 transcription factor network—HLA-A—malignant glioma	0.00229	0.00423	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—malignant glioma	0.00228	0.00422	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—PIK3CA—malignant glioma	0.00228	0.00421	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.00225	0.00417	CbGpPWpGaD
Fludrocortisone—NR3C1—cerebellum—malignant glioma	0.00224	0.0232	CbGeAlD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NOTCH3—malignant glioma	0.00224	0.00415	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—HIF1A—malignant glioma	0.00219	0.00405	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.00208	0.00384	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—STAT3—malignant glioma	0.00207	0.00383	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—malignant glioma	0.00202	0.00374	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—NOTCH1—malignant glioma	0.00202	0.00373	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NOTCH2—malignant glioma	0.00201	0.00372	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—APC—malignant glioma	0.00197	0.00365	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BRCA2—malignant glioma	0.00197	0.00364	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.00192	0.00355	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.00192	0.00355	CbGpPWpGaD
Fludrocortisone—Testosterone—CYP2B6—malignant glioma	0.00191	0.141	CrCbGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—MDM2—malignant glioma	0.00189	0.00351	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—AKT1—malignant glioma	0.00186	0.00344	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—malignant glioma	0.00185	0.00343	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP2B6—malignant glioma	0.00185	0.136	CrCbGaD
Fludrocortisone—NR3C1—brain—malignant glioma	0.00182	0.0189	CbGeAlD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HES1—malignant glioma	0.00181	0.00335	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.00175	0.00324	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—CDKN2B—malignant glioma	0.00173	0.0032	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—malignant glioma	0.00168	0.00311	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—MDM2—malignant glioma	0.00165	0.00305	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NCOR1—malignant glioma	0.00164	0.00304	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.00163	0.00302	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.00161	0.00299	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—NCOR1—malignant glioma	0.00158	0.00293	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.00158	0.00292	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CDKN2A—malignant glioma	0.00156	0.0029	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—DNMT3B—malignant glioma	0.00153	0.00284	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IFNG—malignant glioma	0.00153	0.00282	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—malignant glioma	0.00152	0.00281	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.00152	0.00281	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—HIST1H3B—malignant glioma	0.00149	0.00276	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.00147	0.00272	CbGpPWpGaD
Fludrocortisone—Triamcinolone—PTGS2—malignant glioma	0.00146	0.108	CrCbGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CXCL8—malignant glioma	0.00142	0.00263	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BAD—malignant glioma	0.00142	0.00262	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—PTEN—malignant glioma	0.00139	0.00257	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HES1—malignant glioma	0.00137	0.00254	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL2—malignant glioma	0.00136	0.00251	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—malignant glioma	0.00134	0.00249	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—malignant glioma	0.00134	0.00247	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—HIF1A—malignant glioma	0.00133	0.00247	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.00131	0.00243	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BRAF—malignant glioma	0.00129	0.00239	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MMP9—malignant glioma	0.00128	0.00237	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—PTEN—malignant glioma	0.00128	0.00236	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—malignant glioma	0.00126	0.00232	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—malignant glioma	0.00125	0.00231	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NOTCH1—malignant glioma	0.00124	0.0023	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—malignant glioma	0.00124	0.0023	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—STAT3—malignant glioma	0.00124	0.0023	CbGpPWpGaD
Fludrocortisone—Betamethasone—PTGS2—malignant glioma	0.0012	0.0881	CrCbGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL2—malignant glioma	0.00119	0.00221	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PPARG—malignant glioma	0.00118	0.00218	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.00117	0.00217	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.00115	0.00213	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—H3F3A—malignant glioma	0.00115	0.00213	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.00114	0.00211	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—PPARG—malignant glioma	0.00113	0.0021	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—EGFR—malignant glioma	0.00113	0.00209	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.00112	0.00208	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BCL2—malignant glioma	0.0011	0.00203	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—AKT1—malignant glioma	0.00108	0.002	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MDM2—malignant glioma	0.00108	0.002	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NOTCH3—malignant glioma	0.00108	0.002	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	0.00107	0.00197	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MYC—malignant glioma	0.00106	0.00196	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NOTCH3—malignant glioma	0.00104	0.00193	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000985	0.00182	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NOTCH2—malignant glioma	0.000968	0.00179	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CASP3—malignant glioma	0.000967	0.00179	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000957	0.00177	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000945	0.00175	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—malignant glioma	0.000943	0.00175	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000942	0.00174	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NOTCH2—malignant glioma	0.000933	0.00173	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000909	0.00168	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—PTEN—malignant glioma	0.000909	0.00168	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000896	0.00166	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000893	0.00165	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000883	0.00163	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TP53—malignant glioma	0.00087	0.00161	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000863	0.0016	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—malignant glioma	0.000862	0.0016	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—CDKN2B—malignant glioma	0.000832	0.00154	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—VEGFA—malignant glioma	0.000821	0.00152	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—CDKN2B—malignant glioma	0.000802	0.00148	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000802	0.00148	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.0008	0.00148	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—AKT1—malignant glioma	0.000799	0.00148	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NOTCH3—malignant glioma	0.000789	0.00146	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NCOR1—malignant glioma	0.000789	0.00146	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—malignant glioma	0.000767	0.00142	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NCOR1—malignant glioma	0.000761	0.00141	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MYC—malignant glioma	0.000755	0.0014	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000753	0.00139	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000747	0.00138	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—EGFR—malignant glioma	0.000739	0.00137	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000717	0.00133	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000715	0.00132	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—DNMT3B—malignant glioma	0.000711	0.00132	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NOTCH2—malignant glioma	0.000708	0.00131	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—KRAS—malignant glioma	0.000698	0.00129	CbGpPWpGaD
Fludrocortisone—Dexamethasone—PTGS2—malignant glioma	0.000695	0.0512	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—STAT3—malignant glioma	0.000695	0.00129	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—HIST1H3B—malignant glioma	0.000691	0.00128	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000685	0.00127	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.00068	0.00126	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—MYC—malignant glioma	0.00067	0.00124	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—malignant glioma	0.000654	0.00121	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—malignant glioma	0.000648	0.0012	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000626	0.00116	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TP53—malignant glioma	0.00062	0.00115	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000612	0.00113	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—CDKN2B—malignant glioma	0.000609	0.00113	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000607	0.00112	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TNF—malignant glioma	0.000602	0.00111	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NOTCH1—malignant glioma	0.000599	0.00111	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000583	0.00108	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000578	0.00107	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000578	0.00107	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NCOR1—malignant glioma	0.000577	0.00107	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PPARG—malignant glioma	0.000566	0.00105	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—PPARG—malignant glioma	0.000545	0.00101	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—DNMT3B—malignant glioma	0.000539	0.000999	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—H3F3A—malignant glioma	0.000534	0.000988	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000531	0.000983	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—HIST1H3B—malignant glioma	0.000524	0.00097	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—AKT1—malignant glioma	0.000524	0.00097	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.00052	0.000963	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000514	0.000951	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NOTCH3—malignant glioma	0.000501	0.000927	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NOTCH2—malignant glioma	0.000449	0.000832	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000438	0.000811	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000434	0.000803	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PPARG—malignant glioma	0.000414	0.000766	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—H3F3A—malignant glioma	0.000405	0.000749	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—CDKN2B—malignant glioma	0.000386	0.000715	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NOTCH3—malignant glioma	0.00038	0.000704	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NCOR1—malignant glioma	0.000366	0.000678	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NOTCH2—malignant glioma	0.000341	0.000631	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—MYC—malignant glioma	0.000323	0.000597	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—MYC—malignant glioma	0.000311	0.000575	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—CDKN2B—malignant glioma	0.000293	0.000542	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NOTCH1—malignant glioma	0.000278	0.000515	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NCOR1—malignant glioma	0.000278	0.000514	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PPARG—malignant glioma	0.000263	0.000486	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—MYC—malignant glioma	0.000236	0.000437	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—AKT1—malignant glioma	0.000224	0.000414	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NOTCH1—malignant glioma	0.000211	0.000391	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PPARG—malignant glioma	0.000199	0.000369	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MYC—malignant glioma	0.00015	0.000277	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MYC—malignant glioma	0.000114	0.00021	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—AKT1—malignant glioma	0.000104	0.000192	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AKT1—malignant glioma	7.87e-05	0.000146	CbGpPWpGaD
